← 返回

高脂饮食通过上调结直肠癌中的 CD155 促进肿瘤免疫逃逸

英文原题:High-Fat Diet Promotes Tumor Immune Evasion via CD155 Upregulation in Colorectal Cancer.

查看英文原题

High-Fat Diet Promotes Tumor Immune Evasion via CD155 Upregulation in Colorectal Cancer.

PubMed 2025/12/20(内容时间) Immunol Invest Q3 · IF 2.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

HFD 诱导的代谢应激通过 STAT3/CD155 轴驱动免疫逃逸。靶向该通路可能改善肥胖相关癌症中 ICB 的疗效。

研究思路结论见上方概要

肥胖诱导的代谢应激会损害免疫检查点阻断(ICB)疗法的疗效,但高脂饮食(HFD)与免疫抑制之间的联系机制仍不清楚。

探讨HFD诱导的代谢变化如何通过STAT3/CD155轴调节肿瘤免疫微环境。

在正常或HFD条件下,使用对照、CD155过表达(CD155 OE)和STAT3敲低的CT26细胞建立了小鼠结直肠癌模型,并给予抗PD-L1治疗。通过流式细胞术、Western blotting和染色质免疫沉淀分析了肿瘤生长、免疫浸润和基因表达。

HFD损害了抗PD-L1疗效并加速了肿瘤生长。机制上,HFD促进了STAT3核转位和CD155上调,减少了CD8+ T细胞浸润并增强了调节性T细胞积聚。染色质免疫沉淀证实了STAT3直接结合CD155启动子,而STAT3敲低逆转了这些效应并在HFD喂养小鼠中恢复了抗肿瘤免疫。

展开英文摘要原文

Obesity-induced metabolic stress impairs the efficacy of immune checkpoint blockade (ICB) therapy, but the mechanisms linking a high-fat diet (HFD) to immune suppression remain unclear.

To investigate how HFD-induced metabolic changes modulate the tumor immune microenvironment through the STAT3/CD155 axis.

Murine colorectal cancer models using control, CD155-overexpressing (CD155 OE), and STAT3 knockdown CT26 cells were established under normal or HFD conditions with anti - PD-L1 treatment. Tumor growth, immune infiltration, and gene expression were analyzed by flow cytometry, Western blotting, and chromatin immunoprecipitation.

HFD impaired anti - PD-L1 efficacy and accelerated tumor growth. Mechanistically, HFD promoted STAT3 nuclear translocation and CD155 upregulation, reducing CD8 + T cell infiltration and enhancing regulatory T cell accumulation. Chromatin immunoprecipitation confirmed direct STAT3 binding to the CD155 promoter, while STAT3 knockdown reversed these effects and restored antitumor immunity in HFD-fed mice.

HFD-induced metabolic stress drives immune evasion via the STAT3/CD155 axis. Targeting this pathway may improve ICB efficacy in obesity-related cancers.

论文信息

作者
Liu L、Mo L、Fang J、Ling M、Lei Y、Wen Z、Liang G、Guo J
单位
Department of Oncology and Hematology, He Xian Memorial Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.China
期刊
Immunological investigations2026 Feb
原文标识
PubMed 41420878 · DOI 10.1080/08820139.2025.2600597